Karah Hila — SEC Form 4 filings

SEC reporting owner CIK 1668116. 5 Form 4 filings on record with FilingPulse; latest filed 2025-09-15.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-03-08 to 2025-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Indaptus Therapeutics, Inc. (INDP)Director36
DarioHealth Corp. (DRIO)Director22

Form 4 filings — Karah Hila

FiledFormIssuerReported transactionsSource
2025-09-154DarioHealth Corp. (DRIO)Grant/award (A): 20,000 @ $0EDGAR
2025-06-114Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2025-04-114Indaptus Therapeutics, Inc. (INDP)Disposition to issuer (D): 500 (derivative) @ $0.39 · Disposition to issuer (D): 250 (derivative) @ $0.39 · Disposition to issuer (D): 281 (derivative) @ $0.39 · Disposition to issuer (D): 250 (derivative) @ $0.39EDGAR
2024-06-074Indaptus Therapeutics, Inc. (INDP)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-03-084DarioHealth Corp. (DRIO)Grant/award (A): 70,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1668116 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →